Bank of New York Mellon »

Apogee Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-03-31 $9.1M 137k 66.45
2023-12-31 $1.8M 66k 27.94
2023-09-30 $1.3M 60k 21.30

More positions owned by Bank of New York Mellon

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Inc-class A Cl A (META)
Alphabet Inc-cl A Cap (GOOGL)
Alphabet Inc-cl C Cap (GOOG)
Ishares Core S&p 500 Etf Core (IVV)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc-cl B CL B (BRK.B)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Mastercard Inc - A Cl A (MA)
Exxon Mobil Corporation (XOM)
UnitedHealth (UNH)

View all positions for Bank of New York Mellon

Top funds holding Apogee Therapeutics

VR Adviser
Fairmount Funds Management
RA Capital Management
Perceptive Advisors
Wellington Management Company
OrbiMed Advisors
Vanguard Group
Franklin Resources
T. Rowe Price Associates
Point72 Asset Management
Braidwell
Bank of America Corporation
Henderson Group
Dr. Jeffrey R. Jay, M.D.
Frazier Life Sciences Management

View all funds holding Apogee Therapeutics